Alto Neuroscience Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANRO and other ETFs, options, and stocks.About ANRO
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population.
CEOAmit Etkin
CEOAmit Etkin
Employees76
Employees76
HeadquartersMountain View, California
HeadquartersMountain View, California
Founded2019
Founded2019
Employees76
Employees76
ANRO Key Statistics
Market cap415.68M
Market cap415.68M
Price-Earnings ratio-5.78
Price-Earnings ratio-5.78
Dividend yield—
Dividend yield—
Average volume434.95K
Average volume434.95K
High today$13.83
High today$13.83
Low today$12.93
Low today$12.93
Open price$13.60
Open price$13.60
Volume198.13K
Volume198.13K
52 Week high$16.49
52 Week high$16.49
52 Week low$1.60
52 Week low$1.60
Stock Snapshot
Alto Neuroscience Inc.(ANRO) stock is priced at $13.36, giving the company a market capitalization of 415.68M. It carries a P/E multiple of -5.78.
On 2025-11-25, Alto Neuroscience Inc.(ANRO) stock moved within a range of $12.93 to $13.83. With shares now at $13.36, the stock is trading +3.3% above its intraday low and -3.4% below the session's peak.
Trading activity shows a volume of 198.13K, compared to an average daily volume of 434.95K.
The stock's 52-week range extends from a low of $1.60 to a high of $16.49.
The stock's 52-week range extends from a low of $1.60 to a high of $16.49.
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own ANRO. This list is generated using Robinhood data, and it’s not a recommendation.